Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 2:29 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 58 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intravenous Access Clear all

Conditions: IV Catheter-Related Infection or Complication, Vascular Access Complication, Peripheral Venous Access
Interventions: Extended dwell catheters; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Difficult Intravenous Access
Interventions: Recording number of IV attempts; Other
Lead sponsor: Ralph Beltran; Other
Eligibility: Up to 18 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: IV Cannulation
Interventions: Not listed
Lead sponsor: Peter Szmuk; Other
Eligibility: Up to 18 Years
Enrollment: 603 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Synovial Sarcoma, Myxoid Liposarcoma
Interventions: Non-conforming afamitresgene autoleucel; Genetic
Lead sponsor: USWM CT, LLC; Industry
Eligibility: 18 Years and older
U.S. locations: 11
States / cities: Phoenix, Arizona • Stanford, California • Jacksonville, Florida + 7 more

Conditions: Vascular Access Complication, Central Line Complication, Central Line-Associated Infection, Superficial Vein Thrombosis, Deep Vein Thrombosis
Interventions: Midline catheter; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection
Interventions: B.Braun 6.35 cm 20 Gauge ultralong intravenous catheter, B.D Accucath 5.71 cm 20 Gauge ultralong intravenous catheter; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Vascular Access Device Complications, Catheterization, Peripheral
Interventions: Osprey IV, Historical Controls; Device · Other
Lead sponsor: Community Medical Center, Toms River, NJ; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Toms River, New Jersey

Conditions: Breast Cancer, Melanoma, Thoracic Cancer, Lymphedema of Upper Arm
Interventions: Ipsilateral peripheral IV insertion; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Understanding Emergency Room Procedures
Interventions: Survey; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years to 100 Years
Enrollment: 1,180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Difficult IV Access
Interventions: ultrasound; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hepatitis C, HIV Infections
Interventions: Peer Mentoring Intervention for HCV-Infected IDUs; Behavioral
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 35 Years
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 3
States / cities: Baltimore, Maryland • New York, New York • Seattle, Washington

Conditions: Healthy
Interventions: RN316; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Phoenix, Arizona • Miami Gardens, Florida

Conditions: Venous Access
Interventions: Intravenous access method; Procedure
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Trehalose; Drug
Lead sponsor: Seelos Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
U.S. locations: 21
States / cities: Phoenix, Arizona • Orange, California • San Francisco, California + 16 more

Conditions: Peripheral Venous Catheterization, Difficult Intravenous Access, Catheterization, Peripheral
Interventions: Ultrasound-Guided Peripheral Vascular Access, Standard Peripheral Vascular Access, Point-of-Care Ultrasound System for Vascular Access Guidance; Procedure · Device
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: Locally Advanced or Metastatic HER2-Expressing Cancers
Interventions: VIR-5818, pembrolizumab; Drug
Lead sponsor: Vir Biotechnology, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 645 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Duarte, California

Conditions: Pain
Interventions: Gebauer Ethyl Chloride, Nature's Tears; Drug
Lead sponsor: Aultman Health Foundation; Other
Eligibility: 18 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Canton, Ohio

Conditions: Pain Management, Anxiety
Interventions: Buzzy, Placebo; Device · Other
Lead sponsor: Kyle Stein; Other
Eligibility: 18 Years to 40 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Vascular Access Complications
Interventions: AccuCath IV Catheter System, Conventional IV Catheter System; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Unspecified Adult Solid Tumor, Protocol Specific, Vascular Access Device Complications
Interventions: vascular access device placement; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Hunter Syndrome
Interventions: Idursulfase-IT; Drug
Lead sponsor: Takeda; Industry
Eligibility: Male only
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 17
States / cities: Phoenix, Arizona • Oakland, California • Wilmington, Delaware + 14 more

Conditions: Vascular Access Complication
Interventions: RIVS vascular access, Conventional vascular access; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 5 Years to 90 Years
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 3
States / cities: Fremont, California • Jacksonville, Florida • Cleveland, Ohio

Conditions: PORTs/Peripheral IVs Complication Rates
Interventions: Not listed
Lead sponsor: C. R. Bard; Industry
Eligibility: 21 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Quincy, Illinois • Shreveport, Louisiana

Conditions: Catheter Complications
Interventions: Standard Long IV 4.78 cm 20 g catheter, Ultra-Long IV 6.35 cm 20 g catheter; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Royal Oak, Michigan

Search by objective public record fields.

Blood Sampling Functionality of Extended Dwell Catheters

Prospective Observational Study of Difficult Intravenous Access in the Operating Room

Use of Vein Viewer for Insertion of Peripheral Venous Cannula in Pediatric Patients With Difficult Intravenous Access

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

Novel Strategy to Encourage Early Removal of Central Venous Catheters

Evaluating the Role of the Guidewire in Peripheral Intravenous Access

Does a Novel Needle Over Catheter Device Improve First Pass Success and Decrease Complications

Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study)

Difficult Intravenous Access Perception: Difficult IV Access - Assessment of Patient Understanding

Ultrasound Guidance for Intravenous Cannulation in Emergency Department Patients.

Study to Reduce Intravenous Exposures (STRIVE)

A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult Subjects

Long Versus Short Axis Approach for Ultrasound Guided Peripheral Intravenous Access

Intermediate-Sized Expanded Access Study

TruVascular Access - Ultrasound-Guided Vascular Access Study

To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

Vapocoolant Spray Used Prior to Intravenous (IV) Insertions

Effectiveness of External Vibration for Pain Relief During Intravenous Access in Adult Patients

Comparison of AccuCath IV Catheter and Conventional IV Catheter in Interventional Radiology

Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter

Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs

Ultrasound Guided Catheter Length Survivability